Reported Q: Q4 2024 Rev YoY: N/A EPS YoY: N/A Move: +0.00%
Embracing Future Holdings
8YY.SI
SGD0.0500 0.00%
Exchange SES Sector Healthcare Industry Medical Diagnostics Research
Q4 2024
Published: Dec 31, 2024

Company Status Snapshot

Fast view of the latest quarter outcome for 8YY.SI

Reported

Report Date

Dec 31, 2024

Quarter Q4 2024

Revenue

15.00K

YoY: N/A

EPS

0.00

YoY: N/A

Market Move

+0.00%

Previous quarter: Q2 2024

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • Revenue of $0.02M up 0% year-over-year
  • EPS of $0.00 increased by 0% from previous year
  • Gross margin of -40.0%
  • Net income of -420.00K
  • "" -
8YY.SI
Company 8YY.SI

Swipe to view all report sections

Executive Summary

Embracing Future Holdings Limited reported a challenging QQ4 2024, with revenue of SGD 15,000 and a gross loss of SGD 6,000, yielding a negative gross margin of 40%. The company posted an operating loss of SGD 271,000 and a net loss of SGD 420,000, with EBITDA of SGD -398,000 (EBITDA margin -26.5%). While quarterly EBITDA and net income showed improvement relative to the prior reported quarter in the four-quarter series, the business remains in a cash-burn phase, signalling ongoing dependence on external funding to sustain operations. Free cash flow was negative by SGD 1.934 million for the period, and net cash used in operating activities stood at SGD -1.928 million. The company augmented liquidity via financing activities, with SGD 2.075 million raised through common stock issuance, ending the period with SGD 0.295 million in cash. On the balance sheet, total assets reached SGD 4.669 million, while total liabilities of SGD 2.936 million and total stockholders’ equity of SGD 1.732 million reflect a capital-intensive, early-stage diagnostics player with meaningful goodwill and intangible assets (SGD 2.495 million and SGD 1.441 million respectively).

The QQ4 2024 results underscore a company in the early stages of commercializing precision diagnostics, facing a steep path to achieving unit economics. Revenue remains minimal (Q4 2024 SGD 15k) against a substantial fixed cost base (operating expenses SGD 265k and other expenses SGD 265k in the quarter). Although there are QoQ improvements in EBITDA and net income vs Q2 2024 within the four-quarter window, the core profitability gap remains material. The lack of formal forward guidance in the data necessitates a cautious, scenario-based outlook focused on revenue scale, cost rationalization, and liquidity management going forward.

Key Performance Indicators

Revenue
Stable
15.00K
QoQ: N/A | YoY: N/A
Gross Profit
Stable
-6.00K
-40.00% margin
QoQ: N/A | YoY: N/A
Operating Income
Stable
-271.00K
QoQ: N/A | YoY: N/A
Net Income
Stable
-420.00K
QoQ: N/A | YoY: N/A
EPS
Stable
0.00
QoQ: N/A | YoY: N/A

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q4 2025 3.51 0.00 +8.0% View
Q2 2025 0.88 0.00 +0.0% View
Q1 2025 0.88 0.00 +0.0% View
Q4 2024 0.02 0.00 +0.0% View
Q2 2024 0.04 0.00 +0.0% View